71288-174 : Dacarbazine 200 mg/20ml Intravenous Injection, Powder, for Solution


NDC: 71288-174
Labeler: Meitheal Pharmaceuticals Inc.
Product Type: Human Prescription Drug
Drug Name: Dacarbazine
Dosage Form: Intravenous Injection, Powder, for Solution
Application #: ANDA075259
Rev. Date: 


NDC Package Codes:

  • 71288-174-21: 10 VIAL, SINGLE‑USE IN 1 CARTON (71288‑174‑21) / 20 ML IN 1 VIAL, SINGLE‑USE (71288‑174‑20)

Active Ingredients:

  • Dacarbazine

Dosage Strength:

  • 200 mg/20mL

Pharmaceutical Classes:

  • Alkylating Activity [MoA]
  • Alkylating Drug [EPC]

Related Products:

Based on records with the same trade name.
  • 0143-9245 Dacarbazine 10 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
  • 0703-5075 Dacarbazine 200 mg/20ml Intravenous Injection by Teva Parenteral Medicines, Inc
  • 61703-327 Dacarbazine 200 mg/1 Intravenous Injection, Powder, for Solution by Hospira Worldwide, Inc.
  • 63323-127 Dacarbazine 10 mg/ml Intravenous Injection, Powder, for Solution by App Pharmaceuticals, LLC
  • 63323-128 Dacarbazine 10 mg/ml Intravenous Injection, Powder, for Solution by App Pharmaceuticals, LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 71288-174 QR Code

< Prev: 71288-172Next: 71288-200 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.